{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:16:50Z","timestamp":1762543010146,"version":"3.37.3"},"reference-count":25,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,3,12]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>ITK inhibitors perturb functional changes due to polarizing culture conditions in normal human tonsil CD4+ T cells. Primary human PTCL cells alter their functional properties in culture and ITK inhibitors modify these changes.<\/jats:p>","DOI":"10.1182\/bloodadvances.2018027821","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T16:45:24Z","timestamp":1551285924000},"page":"705-710","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Interleukin-2\u2013inducible T-cell kinase inhibitors modify functional polarization of human peripheral T-cell lymphoma cells"],"prefix":"10.1182","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7014-5481","authenticated-orcid":false,"given":"Sami","family":"Mamand","sequence":"first","affiliation":[{"name":"Leicester Cancer Research Centre and Ernest and Helen Scott Haematology Research Institute, University of Leicester, Leicester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Carr","sequence":"additional","affiliation":[{"name":"Leicester Cancer Research Centre and Ernest and Helen Scott Haematology Research Institute, University of Leicester, Leicester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca L.","family":"Allchin","sequence":"additional","affiliation":[{"name":"Leicester Cancer Research Centre and Ernest and Helen Scott Haematology Research Institute, University of Leicester, Leicester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Ahearne","sequence":"additional","affiliation":[{"name":"Leicester Cancer Research Centre and Ernest and Helen Scott Haematology Research Institute, University of Leicester, Leicester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8914-0370","authenticated-orcid":false,"given":"Simon D.","family":"Wagner","sequence":"additional","affiliation":[{"name":"Leicester Cancer Research Centre and Ernest and Helen Scott Haematology Research Institute, University of Leicester, Leicester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"issue":"1","key":"2020021108264281400_B1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-065X.2010.00951.x","article-title":"Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors","volume":"238","author":"Zhu","year":"2010","journal-title":"Immunol Rev"},{"issue":"3","key":"2020021108264281400_B2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nri.2015.18","article-title":"Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease","volume":"16","author":"DuPage","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"23","key":"2020021108264281400_B3","doi-asserted-by":"crossref","first-page":"11194","DOI":"10.1073\/pnas.89.23.11194","article-title":"itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2","volume":"89","author":"Siliciano","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2020021108264281400_B4","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1084\/jem.187.10.1721","article-title":"T cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T cells","volume":"187","author":"Liu","year":"1998","journal-title":"J Exp Med"},{"issue":"1","key":"2020021108264281400_B5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-065X.2008.00757.x","article-title":"Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk\/Txk","volume":"228","author":"Readinger","year":"2009","journal-title":"Immunol Rev"},{"issue":"6","key":"2020021108264281400_B6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/1074-7613(95)90065-9","article-title":"Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk","volume":"3","author":"Liao","year":"1995","journal-title":"Immunity"},{"issue":"10","key":"2020021108264281400_B7","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.cub.2004.04.011","article-title":"Requirement for Tec kinases in chemokine-induced migration and activation of Cdc42 and Rac","volume":"14","author":"Takesono","year":"2004","journal-title":"Curr Biol"},{"issue":"4","key":"2020021108264281400_B8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nri1591","article-title":"TEC-family kinases: regulators of T-helper-cell differentiation","volume":"5","author":"Schwartzberg","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2020021108264281400_B9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1084\/jem.20131459","article-title":"Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells","volume":"211","author":"Gomez-Rodriguez","year":"2014","journal-title":"J Exp Med"},{"issue":"20","key":"2020021108264281400_B10","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"25","key":"2020021108264281400_B11","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"issue":"11","key":"2020021108264281400_B12","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"issue":"3","key":"2020021108264281400_B13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI26833","article-title":"Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets","volume":"117","author":"Piccaluga","year":"2007","journal-title":"J Clin Invest"},{"issue":"10","key":"2020021108264281400_B14","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1097\/PAS.0000000000000309","article-title":"Intracellular TCR-signaling pathway: novel markers for lymphoma diagnosis and potential therapeutic targets","volume":"38","author":"Agostinelli","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"2020021108264281400_B15","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1158\/1078-0432.CCR-16-1996","article-title":"T-cell receptor signaling activates an ITK\/NF-\u03baB\/GATA-3 axis in T-cell lymphomas facilitating resistance to chemotherapy [published correction appears in Clin Cancer Res. 2017;23(19):5995]","volume":"23","author":"Wang","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2020021108264281400_B16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1215637","article-title":"Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia","volume":"369","author":"Byrd","year":"2013","journal-title":"N Engl J Med"},{"issue":"15","key":"2020021108264281400_B17","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1182\/blood-2013-06-507947","article-title":"Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes","volume":"122","author":"Dubovsky","year":"2013","journal-title":"Blood"},{"issue":"5","key":"2020021108264281400_B18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ni.2261","article-title":"The development and fate of follicular helper T cells defined by an IL-21 reporter mouse","volume":"13","author":"L\u00fcthje","year":"2012","journal-title":"Nat Immunol"},{"author":"Takai","key":"2020021108264281400_B19","article-title":"Discovery of highly selective Itk inhibitors with in vivo IL-2 inhibition"},{"issue":"1","key":"2020021108264281400_B20","doi-asserted-by":"crossref","first-page":"14216","DOI":"10.1038\/s41598-018-32634-5","article-title":"Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma","volume":"8","author":"Mamand","year":"2018","journal-title":"Sci Rep"},{"issue":"3","key":"2020021108264281400_B21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/sji.12333","article-title":"Targets for ibrutinib beyond B cell malignancies","volume":"82","author":"Bergl\u00f6f","year":"2015","journal-title":"Scand J Immunol"},{"issue":"7090","key":"2020021108264281400_B22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"issue":"8","key":"2020021108264281400_B23","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1182\/bloodadvances.2017011916","article-title":"Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma","volume":"2","author":"Kumar","year":"2018","journal-title":"Blood Adv"},{"issue":"4","key":"2020021108264281400_B24","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.immuni.2011.07.015","article-title":"Functional and epigenetic studies reveal multistep differentiation and plasticity of in vitro-generated and in vivo-derived follicular T helper cells","volume":"35","author":"Lu","year":"2011","journal-title":"Immunity"},{"issue":"21","key":"2020021108264281400_B25","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1182\/blood-2018-04-840538","article-title":"Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma","volume":"132","author":"Lemonnier","year":"2018","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/5\/705\/1631319\/advances027821.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/5\/705\/1631319\/advances027821.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T08:44:08Z","timestamp":1581410648000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/3\/5\/705\/246731\/Interleukin2inducible-Tcell-kinase-inhibitors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,27]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,3,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018027821","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"type":"print","value":"2473-9529"},{"type":"electronic","value":"2473-9537"}],"subject":[],"published":{"date-parts":[[2019,2,27]]}}}